NOUVEAU DÉRIVÉ DE PYRIMIDINE AYANT POUR EFFET D'INHIBER LA CROISSANCE DE CELLULES CANCÉREUSES, ET COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI

• 收藏
• 分享

专利权人:

Oncobix Co.; Ltd.

发明人:

申请号：

EP18886173.6

公开号：

EP3722292A1

申请日:

2018.12.06

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present invention provides a novel pyrimidine derivative compound and a salt thereof. The pyrimidine derivative compound effectively inhibits the growth of C797S mutant EGFR-expressed and MET-amplified cancer cells, which are the main resistance mechanisms of third generation EGFR anticancer agents, and thus may be effectively used in the treatment of lung cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/